These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 10890580)
61. Comparative bioavailability study of cefuroxime axetil (equivalent to 500 mg cefuroxime/tablet) tablets (Zednad® versus Zinnat®) in healthy male volunteers. Asiri YA; Al-Hadiya BM; Kadi AA; Al-Khamis KI; Mowafy HA; El-Sayed YM Int J Clin Pharmacol Ther; 2011 Sep; 49(9):571-6. PubMed ID: 21888870 [TBL] [Abstract][Full Text] [Related]
62. Evaluation of the bioequivalence and pharmacokinetics of two lisinopril tablet formulations after single oral administration in healthy volunteers. Georgarakis M; Tsakalof A; Zougrou F; Kontopoulos G; Tsiptsios I Arzneimittelforschung; 2004; 54(1):15-9. PubMed ID: 14979604 [TBL] [Abstract][Full Text] [Related]
63. Bioequivalence evaluation of single doses of two tramadol formulations: a randomized, open-label, two-period crossover study in healthy Brazilian volunteers. Silva Mde F; Schramm SG; Kano EK; Mori Koono EE; Porta V; dos Reis Serra CH Clin Ther; 2010 Apr; 32(4):758-65. PubMed ID: 20435245 [TBL] [Abstract][Full Text] [Related]
64. Bioequivalence of two tablet formulations of atenolol after single oral administration in healthy volunteers. Niopas I; Daftsios AC; Xanthakis I; Nikolaidis N; Njau SN Arzneimittelforschung; 2000 Mar; 50(3):243-7. PubMed ID: 10758775 [TBL] [Abstract][Full Text] [Related]
65. Bioequivalence of allopurinol and its metabolite oxipurinol in two tablet formulations. Guerra P; Frias J; Ruiz B; Soto A; Carcas A; Govantes C; Montuenga C; Fernández A J Clin Pharm Ther; 2001 Apr; 26(2):113-9. PubMed ID: 11350534 [TBL] [Abstract][Full Text] [Related]
66. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers. Iqbal M; Khuroo A; Batolar LS; Tandon M; Monif T; Sharma PL Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995 [TBL] [Abstract][Full Text] [Related]
67. Bioequivalence study of rofecoxib tablets. Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS Arzneimittelforschung; 2004 Sep; 54(9A):624-8. PubMed ID: 15497671 [TBL] [Abstract][Full Text] [Related]
68. Bioequivalence study of two tablet formulations of ramipril in healthy volunteers. Allegrini A; Nuzzo L; Zucchelli M; Tavella-Scaringi A; Bucci M; Pavone D; Toniato E; Mezzetti A; Martinotti S; Bonani S Arzneimittelforschung; 2009; 59(8):392-6. PubMed ID: 19813461 [TBL] [Abstract][Full Text] [Related]
69. Bioequivalence of a New Oral Levosulpiride Formulation Compared With a Standard One in Healthy Volunteers. De Gregori S; Cipollina L; De Silvestri A; Ventura M; Michelini R; Morosini M; Montagna M; Tinelli C; Regazzi M; Molinaro M; Imberti R Ther Drug Monit; 2017 Apr; 39(2):118-123. PubMed ID: 28196046 [TBL] [Abstract][Full Text] [Related]
70. Bioequivalence of two rimantadine tablet formulations in healthy male volunteers after single dose administration. Chládek J; Sispera L; Martinková J; Zaludek B; Sova P; Mièuda S; Grim J; Cermanová J; Zaludek B; Sova P; Franc A Int J Clin Pharmacol Ther; 2001 Apr; 39(4):179-84. PubMed ID: 11332875 [TBL] [Abstract][Full Text] [Related]
71. [The bioequivalence of two nifedipine fluid capsules]. Thürmann P; Bacracheva N Arzneimittelforschung; 1989 Dec; 39(12):1597-9. PubMed ID: 2624612 [TBL] [Abstract][Full Text] [Related]
72. Pharmacokinetic study and comparative bioavailability of two nelfinavir tablet formulations in Iranian healthy volunteers after a low-dose administration. Derakhshandeh K; Sohrabi A Int J Clin Pharmacol Ther; 2009 Jul; 47(7):491-8. PubMed ID: 19640357 [TBL] [Abstract][Full Text] [Related]
73. Evaluation of the bioequivalence and pharmacokinetics of two formulations of secnidazole after single oral administration in healthy volunteers. Zhu DQ; Hu KL; Tao WX; Feng L; Duan H; Jiang XG; Chen J Arzneimittelforschung; 2007; 57(11):723-6. PubMed ID: 18193695 [TBL] [Abstract][Full Text] [Related]
74. Pharmacokinetics of Nifedipine-Sustained Release Tablets in Healthy Subjects After a Single Oral Administration: Bioequivalence Analysis and Food Effects. Wu YX; Zhong XF; Li XM; Liu WL; Zhang YX; Shen QY; Xu SM; Xu PS Clin Pharmacol Drug Dev; 2023 Nov; 12(11):1076-1081. PubMed ID: 37243536 [TBL] [Abstract][Full Text] [Related]
75. Formulation dependent pharmacokinetics--does the dosage form matter for nifedipine? Toal CB J Cardiovasc Pharmacol; 2004 Jul; 44(1):82-6. PubMed ID: 15175561 [TBL] [Abstract][Full Text] [Related]
76. Bioequivalence assessment of two different tablet formulations of diltiazem after single and repeated doses in healthy subjects. Loffreda A; Matera MG; Vacca C; Motola G; De Santis D; Ruggiero A; Russo F; Fici F; Cantoni V; Lampa E; Rossi F Curr Med Res Opin; 1999; 15(1):53-61. PubMed ID: 10216812 [TBL] [Abstract][Full Text] [Related]
77. Relative bioavailability of four controlled-release nifedipine products. Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Van Dyk M; Van Schalkwyk AM Biopharm Drug Dispos; 1994 Aug; 15(6):493-503. PubMed ID: 7993987 [TBL] [Abstract][Full Text] [Related]
78. Lack of effect of orlistat on the bioavailability of a single dose of nifedipine extended-release tablets (Procardia XL) in healthy volunteers. Melia AT; Mulligan TE; Zhi J J Clin Pharmacol; 1996 Apr; 36(4):352-5. PubMed ID: 8728349 [TBL] [Abstract][Full Text] [Related]
79. Comparative bioavailability of diltiazem in prolonged-release oral preparations. Quiroga PA; Yuln GV; Palummo M; Cingolani A; Dall LL; Volonté MG Drug Dev Ind Pharm; 2001 Nov; 27(10):1099-106. PubMed ID: 11794812 [TBL] [Abstract][Full Text] [Related]
80. Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food. Abrahamsson B; Alpsten M; Bake B; Jonsson UE; Eriksson-Lepkowska M; Larsson A J Control Release; 1998 Mar; 52(3):301-10. PubMed ID: 9743450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]